Craig A. Collard - Chief Executive Officer, Director at Heron Therapeutics, Inc. /De/

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
HRTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Craig A. Collard - trading volume in the past year for Heron Therapeutics, Inc. /De/

Holdings reported by Craig A. Collard for Heron Therapeutics, Inc. /De/

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 262,793 $565 K $2.15 Apr 19, 2024 Direct
Restricted Stock Units 187,500 $403 K $2.15 Apr 3, 2024 Direct Common Stock
Employee Stock Option (Right to Buy) 1,324,502 Jan 19, 2024 Direct Common Stock

Transactions reported by Craig A. Collard for Heron Therapeutics, Inc. /De/

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership